SolutionsQuality Management System

The Life Cycle of a typical drug is shown in the diagram below.  A similar diagram could represent a technology transfer or a scale-up of an existing drug.  It is clear from this picture how Speed to market is a major factor driving development. 

From Good Laboratory Practice (GLP) environment to full-scale Good Manufacturing Practice (GMP), Speed to market can be increased by the transfer of knowledge and experience across these phases. SOLABS platforms match the prevailing protocols and facilitate this knowledge transfer.

Benefits for Manufacturing

SOLABS adopts an integrated approach to GMP documents, records and workflows(processes) management automation. SOLABS business model brings customers the flexibility to address a specific problem within the manufacturing lifecycle (e.g., an SOP process) or adopt a more holistic approach to cover several compliance procedure or documentation processes. SOLABS experience in providing best practice content for controlling cGMP processes is extensive and this can be used to great effect through SOLABS service-based business model.

Benefits for Laboratory Operations

Our business model brings customers the flexibility to address a specific problem within the Laboratory environment, such as the possibility to prepare C of A, print controlled copies of analytical methods or force them to be accessed online.  Being ONE system, SOLABS seamlessly transfer knowledge from Laboratory environment to manufacturing or Clinical.

Benefits for Clinical Research

Our business model provides the flexibility to a small team in Clinical environment to implement SOLABS and expand its use over time while prudcts are being approved.  Being ONE system, SOLABS seamlessly transfer knowledge from Clinical environment to laboratory / manufacturing.